Table of Content - Europe, U.S., And India Liquid Biopsy Market

The Europe, U.S., and India liquid biopsy market is estimated to be valued at USD 169.2 Mn in 2026 and is expected to reach USD 535.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033. The Europe, U.S., and India liquid biopsy market is expected to grow at a fast pace due to the increasing global burden of cancer, increasing demand for less invasive diagnostic technologies, and increasing adoption of precision oncology. Liquid biopsy has become an important tool for early detection of cancer, comprehensive genomic profiling, therapy selection, and treatment monitoring, offering a faster and less invasive alternative to conventional tissue biopsy.

Additionally, the market is driven by the continuous advancements in next generation sequencing (NGS), biomarker discovery and companion diagnostics, along with positive regulatory approvals and increasing reimbursement support in developed countries. Rising investments in oncology research, increasing clinical adoption in hospitals and diagnostic laboratories, and rapid expansion of molecular diagnostics infrastructure in India are expected to further propel the market growth.

Market Dynamics

The Europe, U.S., and India liquid biopsy market is primarily driven by the increasing prevalence of cancer, rising need of early and minimally invasive cancer diagnostics and growing adoption of precision medicine. Development in next-generation sequencing (NGS), companion diagnostics and biomarker analysis, along with favorable regulatory approvals and increasing clinical applications in oncology, are boosting the adoption of liquid biopsy technologies across the region.

However, a number of constraints are present in the market, such as high cost of liquid biopsy tests, limited reimbursement in certain clinical scenarios, and the need for extensive clinical validation and standardized testing protocols. Nevertheless, rising adoption of multi-cancer early detection (MCED) tests, expanding applications in minimal residual disease (MRD) monitoring and therapy response assessment, and increasing investments in molecular diagnostics infrastructure are expected to create significant growth opportunities over the forecast period.

Key Features of the Study

This report provides in-depth analysis of the Europe, U.S., and India liquid biopsy market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Europe, U.S., and India liquid biopsy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Exact Sciences Corporation, Bio-Rad Laboratories, Inc., Natera, Inc., Myriad Genetics, Inc., and Menarini Silicon Biosystems S.p.A
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Europe, U.S., and India liquid biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe, U.S., and India liquid biopsy market

Market Segmentation

Type Insights (Revenue, USD Mn, 2021 - 2033)
- Assay/Kits
- Instruments
- Services and Software
- Accessories and Consumables
Biomarker Type Insights (Revenue, USD Mn, 2021 - 2033)
- CtDNA
- CTCs
- Extracellular Vesicles (EVS)
- Others
Disease Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Lung Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Breast Cancer
- Skin Cancer
- Colorectal Cancer
- Bladder Cancer
- Liver Cancer
- Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Detection/Screening
- Therapy Selection
- Treatment Monitoring
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Cancer Institutes
- Academic and Research Institutes
- Diagnostic Centers/Laboratories
- Others
Key Players Insights
- Hoffmann-La Roche Ltd.
- Guardant Health, Inc.
- Illumina, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Exact Sciences Corporation
- Bio-Rad Laboratories, Inc.
- Natera, Inc.
- Myriad Genetics, Inc.
- Menarini Silicon Biosystems S.p.A

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Europe, U.S., and India Liquid Biopsy Market, By Type
  - Europe, U.S., and India Liquid Biopsy Market, By Biomarker Type
  - Europe, U.S., and India Liquid Biopsy Market, By Disease Indication
  - Europe, U.S., and India Liquid Biopsy Market, By Application
  - Europe, U.S., and India Liquid Biopsy Market, By End User
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
Europe, U.S., and India Liquid Biopsy Market, By Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Assay/Kits
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Instruments
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Services and Software
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Accessories and Consumables
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Europe, U.S., and India Liquid Biopsy Market, By Biomarker Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- CtDNA
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CTCs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Extracellular Vesicles (EVS)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Europe, U.S., and India Liquid Biopsy Market, By Disease Indication, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Lung Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Gastrointestinal Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Prostate Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Breast Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Skin Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Colorectal Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Bladder Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Liver Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Europe, U.S., and India Liquid Biopsy Market, By Application, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Detection/Screening
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Therapy Selection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Treatment Monitoring
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Europe, U.S., and India Liquid Biopsy Market, By End User, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cancer Institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Centers/Laboratories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Competitive Landscape
- Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Guardant Health, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Illumina, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- QIAGEN N.V.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Exact Sciences Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Natera, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Myriad Genetics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Menarini Silicon Biosystems S.p.A
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

Browse 32 market data tables and 28 figures on ‘Liquid Biopsy Market’– Europe, U.S., and India forecast to 2033

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now